Connection
Neriman Gokden to PAX2 Transcription Factor
This is a "connection" page, showing publications Neriman Gokden has written about PAX2 Transcription Factor.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
1.085 |
|
|
|
-
Sharma SG, Gokden M, McKenney JK, Phan DC, Cox RM, Kelly T, Gokden N. The utility of PAX-2 and renal cell carcinoma marker immunohistochemistry in distinguishing papillary renal cell carcinoma from nonrenal cell neoplasms with papillary features. Appl Immunohistochem Mol Morphol. 2010 Dec; 18(6):494-8.
Score: 0.368
-
Gokden N, Gokden M, Phan DC, McKenney JK. The utility of PAX-2 in distinguishing metastatic clear cell renal cell carcinoma from its morphologic mimics: an immunohistochemical study with comparison to renal cell carcinoma marker. Am J Surg Pathol. 2008 Oct; 32(10):1462-7.
Score: 0.317
-
Gokden N, Kemp SA, Gokden M. The utility of Pax-2 as an immunohistochemical marker for renal cell carcinoma in cytopathology. Diagn Cytopathol. 2008 Jul; 36(7):473-7.
Score: 0.311
-
Quick CM, Gokden N, Sangoi AR, Brooks JD, McKenney JK. The distribution of PAX-2 immunoreactivity in the prostate gland, seminal vesicle, and ejaculatory duct: comparison with prostatic adenocarcinoma and discussion of prostatic zonal embryogenesis. Hum Pathol. 2010 Aug; 41(8):1145-9.
Score: 0.088